glp-1 and afib Glucagon-like peptide-1 receptor agonists the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine Glucagon-like peptide 1 receptor agonists:

Cell Metab 16 : 296309

The mechanism of GLP-1 agonists involves slowing gastric emptying, which prolongs the feeling of fullness after eating and, in turn, tends to reduce the frequency of eating

Protein, gene, and cell biologics each present distinct advantages, enabling precise intervention in complex cardiovascular processes such as cardiac remodeling, fibrosis, and lipid metabolism

Significantly decreased insulin and insulin receptor expression was observed in postmortem AD brain tissue, and changes in downstream insulin signaling molecules, including decreased levels of IRS-1/2, PI3K, p-Akt (51, 54)

Temporary dose pauses or step-downs may be needed if side effects are not tolerated